Allergic Conjunctivitis Market - By Disease Type, By Treatment Type & Geography-Forecast (2024 - 2030)

Allergic Conjunctivitis Market Size is forecast to reach $ 2290.9 Million by 2030, at a CAGR of 2.27% during forecast period 2024-2030.Allergic conjunctivitis affects approximately 20% of the world population. Around 98% of the affected population suffers either from seasonal allergic conjunctivitis or perennial allergic conjunctivitis. North America is dominating the Allergic Conjunctivitis Market and holds largest market share, followed by Europe and Asia-Pacific. The prevalence of allergic conjunctivitis is due to increase in the use of chemicals and pollution resulting from urbanization, industrialization and climate change. The increase in awareness of allergic conjunctivitis and its associated medical treatment is one of the factor driving the market.

 

 

Allergic conjunctivitis is an eye inflammation caused by an allergic reaction due to allergens like pollen or mold spores, dust mites and animal fur. The eyeball has a membrane called conjunctiva which is susceptible to irritation from allergens. Allergic conjunctivitis is the body’s reaction to substances which are potentially harmful. There are different types of allergic conjunctivitis such as seasonal allergic conjunctivitis, perennial allergic conjunctivitis, giant papillary conjunctivitis, vernal kerato conjunctivitis and atopic kerato conjunctivitis. Some of the symptoms of allergic conjunctivitis are red, itchy, watery and burning eyes. Allergic conjunctivitis can be treated by oral medications, eye drops or immunotherapy.

• Ophthalmic companies are manufacturing new classes of drugs that target inflammatory pathways or mediators involved in allergic responses during the early and late phases. These drugs are being screened in the animal models which will further aid in identifying the next generation of anti-allergic therapy. 
• Cellular therapy of the corneal stroma is gaining a wide range of interest in the past few years. Researchers along with the pharmaceutical companies are using adipose-derived adult stem cell transplantation in the corneal stroma. These cells have the ability to survive in vivo and produce new collagen which could potentially help remodel and strengthen the cornea in patients with keratoconus.

 

The companies referred in the market research report are Aciex Therapeutics, Alcon/Novartis, Sun Pharma Advanced Research Company Ocular Therapeutix, Sirion Therapeutics, Boehringer Ingelheim and others.

 

 

The report incorporates in-depth assessment of the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis and so on to gauge the impact forces and potential opportunities of the market. Apart from this the report also includes a study of major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers and so on to comprehend the prevailing market dynamics at present and its impact during the forecast period 2024-2030.

 

All our reports are customizable to your company needs to a certain extent, we do provide 20 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.

 

• Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
• Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
• Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
• Analyze the sales and distribution channels across key geographies to improve top-line revenues.
• Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes. 
• Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years. 
• Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.  

Key Market Players:

The Top 5 companies in the Allergic Conjunctivitis Market are:

1. Allergan Plc
2. Novartis AG
3. Bausch + Lomb
4. Johnson & Johnson Vision
5. Sun Pharmaceutical Industries Ltd

For more Lifesciences and Healthcare Market reports, please click here